glp-1 bowel obstruction law office in west virginia The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know The push to make weight-loss

Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats

GLP-1 medications such as semaglutide and dulaglutide have been taking the weight loss world by storm with their potential to not only suppress ones appetite for better portion control, but also to aid with overall body weight and fat loss

Proc Natl Acad Sci U S A 96:4586

Dong CX, Zhao W, Solomon C, Rowland KJ, Ackerley C, Robine S, et al

GLP-1s including Semaglutide (sold under the brand name Ozempic) and Tirzepatide can sometimes lead to reduced fluid intake or changes in digestion, which in turn dehydrate the skin